Skip to main content
. 2020 Feb 28;11:1120. doi: 10.1038/s41467-020-14856-2

Table 2.

Kinetic data for purified XPF–ERCC1 mutants.

Protein Mutant Mutation rationale Vmax (fmol min−1) Km (nM) kcat (s−1) kcat/Km (nM−1 min−1)
XPF WT 104.7 ± 2.8 12.1 ± 1.4 20.9 ± 0.66 1.73
XPF L230R FA 65 ± 2.1 8.1 ± 1.1 13.0 ± 3.3 1.60
XPF L236R FA/CS 91.2 ± 2.5 10.8 ± 1.2 18.2 ± 0.5 1.69
XPF E239K FA 88.9 ± 4.7 12.4 ± 2.1 16.9 ± 0.7 1.36
XPF S786F ICLR deficient 80.9 ± 3.8 32.5 ± 1.5 7.9 ± 0.8 0.24
XPF 323–326 Δ ICLR deficient 120.2 ± 1.4 20.5 ± 0.8 24.2 ± 0.3 1.18
XPF S312A Autoinhibition 126.1 ± 28.2 5.1 13.5 ± 1.8 2.65
XPF W274A, H275A Autoinhibition 193.4 ± 8.6 15.2 ± 2.4 38.7 ± 1.3 2.55
XPF R112A DNA binding 24.5 ± 1.1 4.32 ± 0.63 5.6 ± 0.2 1.30
XPF 829–833 Δ Autoinhibition linker disruption 20.2 ± 0.5 1.9 ± 1.2 3.8 ± 0.2 2.00
XPF R589W XP 8.22 ± 2.6 25.9 ± 6.1 1.4 ± 0.9 0.05
ERCC1 L253A Autoinhibition 33.1 ± 2.7 28.7 ± 22.3 3.4 ± 0.3 0.12

Each kinetic value was obtained from 3 technical replicates (n = 3) ± standard deviation (SD).